Evidence map›Paper›PMID 39944653›Full record

ArticleFrontiers in microbiology2025

Weiwei Ma, Yiyang Zhao, Yuyang Liu, Yanyan Wang, Shuang Yu, Lili Huang

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Comparative Effects of Live and Heat-KilledJournal of microbiology and biotechnology · 2026
    Article
  3. Review
  4. Mechanisms ofCurrent research in food science · 2026
    Article
  5. Foods (Basel, Switzerland) · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weiwei Ma *College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Yiyang Zhao *College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Yuyang LiuCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Yanyan WangCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Shuang YuCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Lili HuangCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Constipation is a common gastrointestinal disorder that can affect quality of life. Probiotics have garnered substantial attention for their potential to alleviate constipation. This study investigates the preventive effects of Methods: Mice were randomly assigned to normal control (NC), constipation model (CM), and low, medium, and high-dose TG11 treatment groups (LG, MG, HG). From days 1-14, LG, MG, and HG groups received 10 Results: TG11 significantly enhanced intestinal motility and maintained fecal water content. It normalized blood levels of MTL, SP, SS, ET-1, Gas, and VIP in constipated mice, promoted short-chain fatty acid production, and improved microbial metabolism. TG11 markedly upregulated mRNA expression of Discussion:

Indexed as

constipationgut microbiotagut peptidesprobioticsSCF/c-kit

Identifiers

PMID39944653
PMCPMC11813947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.